CREB3L2 and thyroid cancer: The recent discovery of a novel CREB3L2-PPARgamma fusion mutation in thyroid carcinoma with t(3;7)(p25;q34), demonstrated that a family of somatic PPARgamma fusion mutations exist in thyroid cancer [41].